Carroll Financial Associates, Inc. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 41 filers reported holding ONCOCYTE CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2018$2,0000.0%8500.0%0.00%
Q2 2018$2,000
+100.0%
8500.0%0.00%
Q1 2018$1,000
-66.7%
8500.0%0.00%
Q4 2017$3,000
-40.0%
8500.0%0.00%
-100.0%
Q3 2017$5,000
+25.0%
8500.0%0.00%
Q2 2017$4,000
-20.0%
8500.0%0.00%
-100.0%
Q1 2017$5,0000.0%8500.0%0.00%0.0%
Q4 2016$5,000
+25.0%
8500.0%0.00%0.0%
Q3 2016$4,000
+33.3%
8500.0%0.00%0.0%
Q2 2016$3,0000.0%8500.0%0.00%0.0%
Q1 2016$3,0008500.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2018
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,596,680$27,155,0004.50%
Family Management Corp 20,550$155,0000.11%
Artal Group S.A. 150,000$1,133,0000.02%
Destination Wealth Management 29,656$224,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$1,095,0000.01%
Carroll Financial Associates, Inc. 850$5,0000.00%
Advisor Group, Inc. 112$1,0000.00%
FIFTH THIRD BANCORP 210$2,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,413$18,0000.00%
View complete list of ONCOCYTE CORP shareholders